KRAS and lung adenocarcinoma: Finally, we validated the in vitro results in KRAS‐mutant patient‐derived xenograft (PDX) and a genetically engineered mouse model (GEMM) of KrasG12D‐induced lung adenocarcinoma that precisely recapitulates the human disease (Jackson et al, 2001).